RxDoctor Payments Data

Ladonna Williams

Psychiatric/Mental Health · Portageville, MONPI 1861826968

Payments from drug & device makers

$1,082in general payments, 2019–2025

Across 68 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$301
  • Otsuka America Pharmaceutical, Inc.$244
  • Johnson & Johnson$216
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$92
  • Neurocrine Biosciences, Inc.$85
  • Lundbeck LLC$28
  • plus $116 from 8 others

What the payments were for

  • Food & beverage$1,03596%
  • Education$474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,082 in reported general payments places this provider in the 55th percentile of 565 psychiatric/mental health providers in Missouri.

See all psychiatric/mental health providers in Missouri

Medicare billing

Part B allowed, 2024
$1,363,968
Medicare patients
309
Services billed
18,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate74$254,181
Abilify MaintenaAripiprazole32$92,984
RexultiBrexpiprazole90$89,522
IngrezzaValbenazine Tosylate32$59,293
VraylarCariprazine Hcl61$39,241
Aripiprazole452$34,826
Chlorpromazine Hcl221$32,963
Paliperidone ErPaliperidone178$19,185
EliquisApixaban20$12,456
Lurasidone Hcl124$10,475
Divalproex Sodium649$9,663
ZenpepLipase/Protease/Amylase13$9,173
TrintellixVortioxetine Hydrobromide18$8,799
Divalproex Sodium ErDivalproex Sodium236$8,690
Quetiapine Fumarate916$7,023

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$216$254,18174 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$244$182,506122 claims
Neurocrine Biosciences, Inc.Ingrezza$85$59,29332 claims
AbbVieVraylar$301$39,24161 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$12$8,79918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 565 psychiatric/mental health providers in Missouri.

Other psychiatric/mental health in Portageville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →